Essential Medical has submitted its CE mark application for MANTA, the company’s large bore vascular closure device.
Boston Scientific’s Jetstream atherectomy system has received CE mark for a new in-stent restenosis indication. This indication gives EU physicians “another safe and effective treatment option for in-stent restenosis, a disease state that has historically been challenging to treat with traditional therapies,” says a Boston Scientific press release.
Integra LifeSciences has received approval from the US Food and Drug Administration (FDA) for the packaging of its new product, Integra Omnigraft Dermal Regeneration Matrix.
Positive twelve-month results from Intact Vascular’s Tack optimised balloon angioplasty—below-the-knee (TOBA-BTK) clinical study have been presented at the SCAI 2016 conference (4–7 May, Orlando, USA) by Christian Wissgott, assistant director at Westküstenklinikum Heide in Heide, Germany.
A pioneering technique significantly reduces phantom pain emanating from the site of amputated limbs, according to findings presented at the Society of Interventional Radiology’s 2016 Annual Scientific Meeting (2–7 April, Vancouver, Canada). The study indicates that interventional radiologists applying cryoablation therapy, a minimally invasive targeted treatment using cold blasts, show promise in improving the quality of life for patients suffering phantom limb pain.
Charles E Ray Jr, an interventional radiologist, and professor and head of the department of radiology at the College of Medicine at the University of Illinois at Chicago, assumed the office of president of the Society of Interventional Radiology during the society’s Annual Scientific Meeting (2–7 April, Vancouver, Canada).
A safe, new, minimally invasive treatment, developed by interventional radiologists, led to sustained weight loss in severely obese people, according to research presented at the Society of Interventional Radiology’s 2016 Annual Scientific Meeting.
Women who underwent embolization for the treatment of uterine fibroids experienced improved sexual function and a higher overall quality of life. The research, part of a French multicentre study, presented at the Society of Interventional Radiology’s Annual Scientific Meeting, also found the vast majority of women treated with the procedure sustained improvement for more than a year.
The study will evaluate two-compartment dosimetry (normal tissue and tumour absorbed dose) in hepatocellular carcinoma patients in interventional oncology in an effort towards a more personalised approach to Y-90 radioembolization for liver cancer patients.
The UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing (MIB) stating that National Health Service (NHS) doctors and commissioners may consider SIR-Spheres Yttrium-90 (Y-90) resin microspheres as an alternative to standard therapy with transarterial chemoembolization (TACE) or sorafenib in the treatment of patients with inoperable primary liver cancer (hepatocellular carcinoma or HCC).
BTG has announced the launch of LC Bead Lumi in the USA, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumours and arteriovenous malformations. LC Bead Lumi is a next generation development of LC Bead.
A study has found that radiofrequency ablation to treat liver metastases in patients with colorectal cancer, induces antitumour immune responses in human samples of primary colon tumour.
Penumbra has announced the launch of the Lantern microcatheter at the upcoming Society of Interventional Radiology annual scientific meeting (SIR 2016, 2-7 April, Vancouver, Canada).
Merit Medical has announced receiving notification of substantial equivalence from the US FDA for the Corvocet Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumours.
Merit Medical Systems has announced its schedule of activity for the upcoming Society of Interventional Radiology (SIR) Meeting, being held in Vancouver, Canada, April 2-7 2016.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos